Ascelia Pharma AB (publ) (ACE) — Financial Flexibility Index
Ascelia Pharma AB (publ) (ACE) has a Financial Flexibility Index of -0.71x as of September 2025. Free cash flow of Skr-15.60 Million (operating CF Skr-15.66 Million minus capex Skr57.00K) represents -1% of total liabilities (Skr22.01 Million). Check ACE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascelia Pharma AB (publ) Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Ascelia Pharma AB (publ) across 8 annual periods. For the full cash flow conversion analysis, see Ascelia Pharma AB (publ) cash flow conversion.
Annual Financial Flexibility Index for Ascelia Pharma AB (publ) (2017–2024)
Year-by-year free cash flow to debt coverage for Ascelia Pharma AB (publ). Explore Ascelia Pharma AB (publ) cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | Skr-62.84 Million | Skr-62.84 Million | Skr61.98 Million | — |
| 2023 | 0.00x | Skr0.00 | Skr-126.79 Million | Skr12.74 Million | ▲ +100.0% |
| 2022 | -3.32x | Skr-125.20 Million | Skr-125.26 Million | Skr37.71 Million | ▲ +26.9% |
| 2021 | -4.54x | Skr-116.52 Million | Skr-116.56 Million | Skr25.66 Million | ▼ -3.0% |
| 2020 | -4.41x | Skr-85.13 Million | Skr-85.53 Million | Skr19.32 Million | ▼ -58.8% |
| 2019 | -2.77x | Skr-36.52 Million | Skr-36.92 Million | Skr13.16 Million | ▼ -5.1% |
| 2018 | -2.64x | Skr-29.94 Million | Skr-30.33 Million | Skr11.35 Million | ▲ +43.3% |
| 2017 | -4.65x | Skr-20.56 Million | Skr-20.96 Million | Skr4.42 Million | — |